Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered (Q36186431)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered |
scientific article |
Statements
1 reference
Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered (English)
1 reference
Lois S Lee
1 reference
Anne N Nafziger
1 reference
Joseph S Bertino
1 reference
1 July 2005
1 reference
1 reference
78
1 reference
1
1 reference
1-6
1 reference
Identifiers
1 reference
1 reference